INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,649,000 | +234.2% | 548,459 | +290.1% | 0.11% | +278.6% |
| Q1 2022 | $2,289,000 | +522.0% | 140,600 | +522.1% | 0.03% | +600.0% |
| Q4 2021 | $368,000 | -59.7% | 22,600 | -38.9% | 0.00% | -81.0% |
| Q4 2020 | $913,000 | -48.8% | 36,971 | -14.0% | 0.02% | -48.8% |
| Q3 2020 | $1,783,000 | +43.0% | 43,000 | +65.4% | 0.04% | -2.4% |
| Q2 2020 | $1,247,000 | -54.1% | 26,000 | -39.8% | 0.04% | -72.7% |
| Q1 2020 | $2,719,000 | -50.7% | 43,200 | -2.9% | 0.15% | -17.2% |
| Q4 2019 | $5,515,000 | +219.7% | 44,500 | +71.2% | 0.19% | +109.0% |
| Q3 2019 | $1,725,000 | -89.0% | 26,000 | -81.5% | 0.09% | -89.7% |
| Q1 2019 | $15,694,000 | – | 140,300 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |